Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner
- PMID: 15970594
- DOI: 10.1074/jbc.M501238200
Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner
Retraction in
-
Retraction: Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- and an AMP kinase-dependent manner.J Biol Chem. 2013 Mar 1;288(9):6583. doi: 10.1074/jbc.A113.501238. J Biol Chem. 2013. PMID: 23457388 Free PMC article. No abstract available.
Abstract
Dietary free fatty acids have been reported to have various effects on the endothelium including the generation of nitric oxide. The goal of the current study was to determine the mechanism whereby free fatty acid causes an increase in nitric oxide synthesis. The specific hypothesis tested was that free fatty acid association with CD36, a class B scavenger receptor, induces the activation of endothelial nitric-oxide synthase (eNOS). A human microvascular endothelial cell line and a transfected Chinese hamster ovary cell system were used to determine which free fatty acids stimulate eNOS. Surprisingly, only myristic acid, and to a lesser extent palmitic acid, stimulated eNOS. The stimulation of eNOS was dose- and time-dependent. Competition experiments with other free fatty acids and with a CD36-blocking antibody demonstrated that the effects of myristic acid on eNOS required association with CD36. Further mechanistic studies demonstrated that the effects of myristic acid on eNOS function were not dependent on PI 3-kinase, Akt kinase, or calcium. Pharmacological studies and dominant negative constructs were used to demonstrate that myristic acid/CD36 stimulation of eNOS activity was dependent on the activation of AMP kinase. These data demonstrate an unexpected link among myristic acid, CD36, AMP kinase, and eNOS activity.
Comment in
-
Findings of research misconduct.NIH Guide Grants Contracts (Bethesda). 2012 Dec 14:NOT-OD-13-014. NIH Guide Grants Contracts (Bethesda). 2012. PMID: 23248821 Free PMC article. No abstract available.
-
Findings of Research Misconduct.Fed Regist. 2012 Nov 20;77(224):69627-69628. Fed Regist. 2012. PMID: 27737224 Free PMC article. No abstract available.
Similar articles
-
High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner.J Biol Chem. 2002 Mar 29;277(13):11058-63. doi: 10.1074/jbc.M110985200. Epub 2002 Jan 15. J Biol Chem. 2002. PMID: 11792700
-
High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.J Biol Chem. 2000 Apr 14;275(15):11278-83. doi: 10.1074/jbc.275.15.11278. J Biol Chem. 2000. PMID: 10753938
-
Diabetic HDL-associated myristic acid inhibits acetylcholine-induced nitric oxide generation by preventing the association of endothelial nitric oxide synthase with calmodulin.Am J Physiol Cell Physiol. 2008 Jan;294(1):C295-305. doi: 10.1152/ajpcell.00042.2007. Epub 2007 Oct 31. Am J Physiol Cell Physiol. 2008. Retraction in: Am J Physiol Cell Physiol. 2013 Apr 15;304(8):C812. doi: 10.1152/ajpcell.zh0-7220-retr.2013. PMID: 17977947 Retracted.
-
Identification of covalently bound amino-terminal myristic acid in endothelial nitric oxide synthase.J Biol Chem. 1994 Apr 22;269(16):11691-4. J Biol Chem. 1994. PMID: 7512951
-
HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action.Trends Cardiovasc Med. 2003 Aug;13(6):226-31. doi: 10.1016/s1050-1738(03)00098-7. Trends Cardiovasc Med. 2003. PMID: 12922018 Review.
Cited by
-
Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.J Biol Chem. 2010 Dec 10;285(50):38923-32. doi: 10.1074/jbc.M110.172304. Epub 2010 Oct 5. J Biol Chem. 2010. PMID: 20923780 Free PMC article.
-
CD36 may determine our desire for dietary fats.J Clin Invest. 2005 Nov;115(11):2965-7. doi: 10.1172/JCI26955. J Clin Invest. 2005. PMID: 16276408 Free PMC article. Review.
-
Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.Curr Drug Targets. 2008 Oct;9(10):833-41. doi: 10.2174/138945008785909338. Curr Drug Targets. 2008. PMID: 18855617 Free PMC article. Review.
-
Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.Nat Rev Cancer. 2009 Mar;9(3):182-94. doi: 10.1038/nrc2561. Epub 2009 Feb 5. Nat Rev Cancer. 2009. PMID: 19194382 Free PMC article. Review.
-
Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.J Biol Chem. 2007 May 25;282(21):15404-15. doi: 10.1074/jbc.M701638200. Epub 2007 Apr 5. J Biol Chem. 2007. PMID: 17416590 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous